Silicon and matrix macromolecules: New research opportunities for old diseases from analysis of potential mechanisms of breast implant toxicity

Medical Hypotheses

Volumn 51, Issue 1, 1998, Pages 27-35

  Brawer, A E ^a,b  

^a MONMOUTH MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; GLYCOPROTEIN; GLYCOSAMINOGLYCAN; ORGANOSILICON DERIVATIVE; SILICON;

BIOENGINEERING; BREAST ENDOPROSTHESIS; EXTRACELLULAR MATRIX; HUMAN; IMMUNOTOXICITY; MACROMOLECULE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SILICONE PROSTHESIS;

EID: 0031816603     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(98)90250-X     Document Type: Article

References (46)

1. Bendz G, Lindqvist I, eds. Biochemistry of Silicon and Related Problems. New York: Plenum, 1978.
2. Yoshida S H, Chang C C, Teuber S S, Gershwin M E. Silicon and silicone: theoretical and clinical implications of breast implants. Regulatory Toxicol Pharmacol 1993; 17: 3-18.
3. Sergent J S, Fuchs H, Johnson J S. Silicone implants and rheumatic diseases. In: Kelley WN, Harris ED, Ruddy S, Sledge C B, eds. Textbook of Rheumatology. Philadelphia: Saunders, 1993: Update 4: 1-3.
4. Evered D, O'Connor M, eds. Silicon Biochemistry. Chichester: Wiley, 1986.
5. Kelley W N, Harris E D, Ruddy S, Sledge C B, eds. Textbook of Rheumatology. Philadelphia: Saunders, 1997.
6. Stryer L. Biochemistry. New York: Freeman, 1995.
7. Campbell A, Brautbar N, Vojdani A. Suppressed natural killer cell activity in patients with silicone breast implants: reversal upon explantation. Toxicol Ind Hlth 1994; 10: 149-154.
8. 2GP1 cofactor [abstr]. Arthritis Rheum 1996; 39(Suppl.): S319.
9. Teuber S S, Yoshida S H, Gershwin E. Immunopathologic effects of silicone breast implants. West J Med 1995; 162: 418-425.
10. Brawer A E. Chronology of systemic disease development in 300 symptomatic recipients of silicone gel-filled breast implants. J Clean Technol, Environ Toxicol, Occupat Med 1996; 5: 223-233.
11. Peters W, Smith D, Lugowski S, McHugh A, MacDonald P, Baines C. Silicon and silicone levels in patients with silicone implants. Curr Top Microbiol Immunol 1996; 210: 39-48.
12. Robinson O G Jr, Bradley E L, Wilson D S. Analysis of explanted silicone implants: a report of 300 patients. Ann Plastic Surg 1995; 34: 1-7.
13. Wolf C J, Brandon H J, Young V L, Jerina K L, Srivastava A P. Chemical, physical and mechanical analysis of explanted breast implants. Curr Top Microbiol Immunol 1996; 210: 25-37.
14. Goldberg E P. Evaluating the health risks of breast implants [letter]. N Engl J Med 1996; 335: 1154.
15. Garrido L, Bogdanova A, Cheng L L et al. Detection of silicone migration and biodegradation with NMR. Curr Top Microbiol Immunol 1996; 210: 49-58.
16. Hardt N S, Emery J A, Steinback B G, LaTorre G, Caffee H. Cellular transport of silicone from breast prostheses. Int J Occupat Med Toxicol 1995; 4: 127-134.
17. Schnur P L, Weinzweig J, Harris J B. Silicon analysis of breast and periprosthetic capsular tissue from patients with saline or silicone gel breast implants. Plast Reconstruc Surg 1996; 98: 798-803.
18. Brawer A E. Clinical features of systemic phenomena in 300 symptomatic recipients of silicone gel-filled breast implants (submitted for publication).
19. Bridges A J, Conley C, Wang G et al. A clinical and immunologic evaluation of women with silicone breast implants and symptoms of rheumatic disease. Ann Intern Med 1993; 11: 929-936.
20. Brawer A E. Bones, groans, and silicone: beauty and the beast [abstr]. Arthritis Rheum 1994; 37(Suppl.): R38.
21. Borenstein D. Siliconosis: a spectrum of illness. Semin Arthritis Rheum 1994; 24(Suppl. 1): 1-7.
22. Solomon G. A clinical and laboratory profile of symptomatic women with silicone breast implants. Semin Arthritis Rheum 1994; 24(suppl. 1): 29-37.
23. Freundlich B, Altman C, Sandorfi N et al. A profile of symptomatic patients with silicone breast implants: a Sjögren's-like syndrome. Semin Arthritis Rheum 1994; 24(Suppl. 1): 44-53.
24. Solomon G. Clinical and serologic features of 639 symptomatic women with silicone gel implants: evidence for a novel disease Siliconosis [abstr]. Arthritis Rheum 1994; 37(Suppl.): S423.
25. Davis J, Campagna J, Perrillo R, Criswell L. Clinical characteristics of 343 patients with breast implants [abstr]. Arthritis Rheum 1995; 38(Suppl.): S263.
26. Mease P J, Overman S S, Green D J. Clinical symptoms/signs and laboratory features in symptomatic patients with silicone breast implants [abstr]. Arthritis Rheum 1995; 38(Suppl.): S324.
27. Vasey F B, Havice D L, Boranegra T S et al. Clinical findings in symptomatic women with silicone breast implants. Semin Arthritis Rheum 1994; 24(Suppl. 1): 22-28.
28. Shoaib B O, Patten B M, Calkins D S. Adjuvant breast disease: an evaluation of 100 symptomatic women with breast implants or silicone fluid injections. Keio J Med 1994; 43: 79-87.
29. Shoaib B O, Patten B M. Human adjuvant disease: presentation as a multiple sclerosis-like syndrome. South Med J 1996; 89: 179-188.
30. Gabriel S E, O'Fallon WM, Kurland L T et al. Risk of connective tissue diseases and other disorders after breast implantation. N Engl J Med 1994; 330: 1697-1702.
31. Sanchez-Guerrero J, Colditz G A et al. Silicone breast implants and the risk of connective tissue diseases and symptoms. N Engl J Med 1995; 332: 1666-1670.
32. Yoshida S H, Swan S, Teuber S S, Gershwin M E. Silicone breast implants: immunotoxic and epidemiologic issues. Life Sci 1995; 56: 1299-1310.
33. Marcus D M. An analytical review of silicone immunology. Arthritis Rheum 1996; 39: 1619-1626.
34. Bennett D R, Gorzinski S J, LeBeau J E. Structure-activity relationships of oral organosiloxanes on the male reproductive system. Toxicol Appl Pharmacol 1972; 21: 55-67.
35. Ben-Hur N, Ballantyne D, Rees T, Seidman I. Local and systemic effects of dimethylpolysiloxane fluid in mice. Plast Reconstr Surg 1967; 43: 423-426.
36. Ferreira M C, Spina V, Iriya K. Changes in the lung following injections of silicone gel. Br J Plast Reconstr Surg 1975; 173-176.
37. Hayden J F, Barlow S A. Structure activity relationships of organosiloxanes and the female reproductive system. Toxicol Appl Pharmacol 1972; 21: 68-79.
38. Palazzolo R J et al. Investigation of the toxicologic properties of a phenylmethylcyclosiloxane. Toxicol Appl Pharmacol 1972; 21: 15-28.
39. Brawer A E. Clinical features of local breast phenomena in 300 symptomatic recipients of silicone gel-filled breast implants. J Clean Technol, Environ Toxicol, Occupat Med 1996; 5: 235-247.
40. Brawer A E. Amelioration of systemic disease after removal of silicone gel-filled breast implants (submitted for publication).
41. Busch H. Silicone toxicology. Semin Arthritis Rheum 1994; (Suppl. 1) 24: 11-17.
42. Dobke M K, Svahn J K, Vastine V L et al. Characterization of microbial presence at the surface of silicone mammary implants. Ann Plast Surg 1995; 34: 563-571.
43. Epstein S S. Implants pose poorly recognized risks of breast cancer. Int J Occup Med Toxicol 1995; 4: 315-342.
44. Steenland K, Goldsmith D F. Silica exposure and autoimmune diseases. Am J Industr Med 1995; 28: 603-608.
45. ACR study group. Silicone related syndromes. Arthritis Rheum 1996; 39(Suppl.): S25.
46. Dayal A K, Kammer G M. The T cell enigma in lupus. Arthritis Rheum 1996; 39: 23-33.